What This Immunome Sale Signals Ahead of FDA Milestone
When a biotech firm nears a major FDA decision, every insider transaction can feel like a tell. This article dives in...
Starting retirement planning at 60 can present unique challenges. Learn how to effectively navigate this stage for a secure future.
20,891 articlesWhen a biotech firm nears a major FDA decision, every insider transaction can feel like a tell. This article dives in...
A rising institutional move shines a light on how large managers deploy capital in broad market ETFs. This piece brea...
A biotech stock surged 75% last quarter and drew a new $9 million investment, signaling confidence from sophisticated...
Goodyear’s stock surged intraday as oil prices pulled back and demand expectations shifted. Learn what drove the move...
A biotech insider sale can spark questions about company momentum. This article digs into the Stoke Therapeutics CMO ...
As earnings season rolls in, KTCC’s tronic 2026 earnings story becomes a focal point for value seekers. This guide br...
A top executive at Rush Street Interactive disclosed a sizable stock sale following a strong earnings report. This ar...
A notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
As TJX prepares for the (tjx) 2027 earnings call, investors are weighing store growth, margins, and online evolution....
When a top Remitly executive sells shares, investors want to know what it means. This guide explains insider sales, h...
When a feud becomes a marketing engine, money talks louder than records. This feature examines how T.I. targets Cent ...
Apple’s next AI chapter hinges on Siri. If the so-called this "siri-ous" problem could derail AI progress, investors ...